The Franklin Lakes, NJ-based company said it would acquire Parata Systems for $1.5 billion.
New Microbiome Wipes eliminate the awkward poop-and-scoop step of at-home microbiome testing.
Data presented at the American Diabetes Association meeting shows that using the Medtronic MiniMed 780G insulin pump improves glycemic outcomes with less effort from patients.
Better Therapeutics, a digital prescription therapeutics company, is the latest to announce a CEO transition. There have been a string of high-level CEO changes this year.
Executives at both Abbott and Dexcom are hopeful that Medicare will extend coverage for continuous glucose monitoring systems to type 2 basal-only patients in 2023, an analyst reports.
This new regulatory framework replaces the IVD Directive, under which Concentriq Dx also received a CE mark.
BD & Certest BioTec are developing a molecular test for the detection of the monkeypox virus.
IME will take place June 14-16 at the Charlotte Convention Center.
A partnership between C2i Genomics and Karkinos Healthcare will enable whole-genome-sequencing minimal residual disease (MRD) cancer testing in India.
Healthcare leaders are re-evaluating priorities to address key challenges coming out of the pandemic, according to a new report published by Philips.
FDA has issued a Class I Recall for the HVAD pump implant kit because of a pump weld defect.